Kalstein

Understanding the Operating Principle and Scientific Foundations of the YR02194 Infant Bilirubin Phototherapy Unit

Av Kalstein · Publicerad:

Kategori:articulos-de-productos

Understanding the Operating Principle and Scientific Foundations of the YR02194 Infant Bilirubin Phototherapy Unit

Explore the operating principle and scientific foundations of the YR02194 Infant Bilirubin Phototherapy Unit. Learn about its design, functionality, and applica

Understanding the Operating Principle and Scientific Foundations of the YR02194 Infant Bilirubin Phototherapy Unit

Understanding the Operating Principle and Scientific Foundations of the YR02194 Infant Bilirubin Phototherapy Unit

The YR02194 Infant Bilirubin Phototherapy Unit is an essential piece of equipment in neonatal care, specifically designed to treat jaundice in infants. Jaundice arises from elevated levels of bilirubin in the blood, which can lead to serious health issues if not appropriately managed. This article delves into the operating principles and scientific foundations that underpin the functionality of the YR02194, ensuring healthcare providers can maximize its potential in clinical settings.

Principle of Operation

The YR02194 operates on the principle of phototherapy, which involves the exposure of the skin to specific wavelengths of light that help reduce bilirubin levels. The unit utilizes four blue fluorescent tube lights that emit light within the wavelength range of 400-550 nm, effectively targeting bilirubin molecules in the skin. This range is crucial as it facilitates the photochemical conversion of toxic bilirubin into a water-soluble form, allowing for easier excretion via the liver and kidneys.

This phototherapy process hinges on the principle of light absorption by bilirubin. The absorption spectrum of bilirubin shows that it effectively absorbs light in the blue spectrum, making the YR02194's design particularly efficient. The unit's design choices, including the arrangement and intensity of the light sources, are engineered to maximize irradiance on the infant's skin while minimizing discomfort.

Scientific Fundamentals of Bilirubin Metabolism

Bilirubin is a byproduct of the breakdown of hemoglobin from red blood cells. In newborns, particularly preterm infants, the liver may not be fully developed, leading to increased levels of unconjugated bilirubin. The phototherapy provided by the YR02194 helps in the conversion of unconjugated bilirubin into conjugated bilirubin, which is water-soluble and can be excreted through urine or feces.

The mechanism behind this is known as 'photoisomerization,' where light energy alters the configuration of bilirubin molecules, facilitating their clearance from the bloodstream. This transformation significantly reduces the risk of kernicterus, a severe form of brain damage resulting from high bilirubin levels.

Technical Specifications of the YR02194

ModelYR02194
Input Power<150VA
Light SourceBlue Tube
Light Source Effective Life1000 hours
Wave Length400-550 nm
Irradiance Treatment Distance10~500px
Effective Area1125px×600px
Infrared Radiation in Effective Area≤10mW/cm² (760nm<λ≤1400nm)
Ultraviolet Radiation in Effective Area≤1.0×10⁻⁵mW/cm² (180nm<λ≤400nm)
Operating Noise≤55 dB(A) (ambient noise lower than 40 dB(A))
Basic PerformanceEquipment total irradiance (Ebi) ≥500μW/cm²
Adjust Angle30°, 60°, 90°
Adjust Height1100mm~1500mm

Design Choices and Functionality

The YR02194's design incorporates several features intended to enhance its effectiveness and usability. The mobile type design allows for easy maneuverability in clinical environments, helping healthcare professionals position the unit optimally based on individual patient needs. Furthermore, the digital LED timer provides a visual representation of therapy duration, enabling caregivers to monitor treatment time accurately.

By using four fluorescent tubes, the unit ensures uniform light distribution across the treatment area. This minimizes the risk of localized overheating of the skin and ensures that the phototherapy is effective throughout the entire surface area exposed to light.

Common Setup and Usage Guidelines

To achieve optimal results with the YR02194, proper setup and usage are essential. Upon unboxing, healthcare providers should check all components, ensuring that the light source is functional and properly aligned. The distance from the infant to the light source should be maintained within the recommended range of 10-500px to ensure adequate exposure without causing discomfort.

Before initiating treatment, caregivers should also calibrate the digital timer to set the appropriate therapy duration based on the infant's bilirubin levels. It is crucial to monitor the infant’s skin condition and temperature throughout the therapy to prevent overheating and skin burns.

Frequently Asked Questions

What wavelength range does the YR02194 utilize for phototherapy?

The YR02194 utilizes a wavelength range of 400-550 nm for phototherapy, specifically targeting bilirubin absorption to aid in its reduction in the bloodstream.

How often should the light source of the YR02194 be replaced?

The light source of the YR02194 has an effective life of 1000 hours. It is recommended to replace the bulbs after this period to ensure maximum efficiency during treatment.

What is the maximum operating noise level of the YR02194?

The maximum operating noise level of the YR02194 is ≤55 dB(A), which ensures a quiet environment for the infant during treatment.

Can the YR02194 be adjusted for different angles?

Yes, the YR02194 allows adjustments at angles of 30°, 60°, and 90° to optimize the light exposure based on the infant's positioning.

What is the effective treatment area of the YR02194?

The effective treatment area of the YR02194 is 1125px×600px, allowing for adequate coverage during phototherapy sessions.

How can I ensure proper setup of the YR02194?

Proper setup includes unboxing and checking all components, ensuring the light source is functional, and maintaining the recommended treatment distance from the infant.

What should I monitor during the use of the YR02194?

While using the YR02194, caregivers should monitor the duration of the therapy, the infant's skin condition, and the ambient temperature to prevent overheating and ensure effective treatment.

For those interested in acquiring this equipment or learning more about its applications, please request a quote on Kalstein Plus.

If you are looking for a fusion of innovation and quality, you have come to the right place. At Kalstein, we offer you the luxury of exploring our exclusive catalog of laboratory equipment. We manufacture every device to the highest standards of excellence. Our intuitive and seamless online purchasing channels are designed for your convenience, securing the most competitive prices. Hesitate no longer — we bring science to life, it is time to become part of our community.

Want to explore this device in depth?

Check the full technical datasheet of Infant bilirubin phototherapy unit YR02194 with all specifications, dimensions, accessories and quote options.
View product datasheet →